Nicolas Shiaelis, Pictura Bio

Founder

Established in 2022 as a spin-out from the University of Oxford, Pictura Bio has developed a device that uses digital technology to analyze medical specimens for pathogens on the spot rather than sending them to a lab. By using optical engineering and machine learning, the company’s test can provide results in less than a minute.